¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"nuclear paralysis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • normokalemic periodic paralysis
    Á¤»óÄ®·ýÁֱ⸶ºñ
  • postdiphtheritic paralysis
    µðÇÁÅ׸®¾ÆÈĸ¶ºñ
  • progressive spastic spinal paralysis
    ÁøÇà°­Á÷ô¼ö¸¶ºñ
  • pseudobulbar paralysis
    °ÅÁþ¼û³ú¸¶ºñ, °ÅÁþ¿¬¼ö¸¶ºñ
  • paralysis
    ¸¶ºñ
  • paralysis agitans
    ¶³¸²¸¶ºñ
  • periodic paralysis
    Áֱ⸶ºñ
  • reflex paralysis
    ¹Ý»ç¸¶ºñ
  • residual paralysis
    ÈÄÀ¯¸¶ºñ
  • radicular paralysis
    ½Å°æ»Ñ¸®¸¶ºñ, ½Å°æ±Ù¸¶ºñ
  • spasmodic spinal paralysis
    ¿¬Ãàô¼ö¸¶ºñ
  • spastic paralysis
    °­Á÷¸¶ºñ
  • spastic spinal paralysis
    °­Á÷ô¼ö¸¶ºñ
  • stationary paralysis
    °íÁ¤¸¶ºñ
  • segmental paralysis
    ºÐÀý¸¶ºñ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • nocturnal paralysis
    ¾ß°£¸¶ºñ
  • paralysis
    ¸¶ºñ
  • paralysis agitans
    ÁøÀü¸¶ºñ
  • postdiphtheritic paralysis
    µðÇÁÅ׸®¾ÆÈĸ¶ºñ
  • progressive spastic spinal paralysis
    ÁøÇà°æÁ÷ô¼ö¸¶ºñ
  • radicular paralysis
    ½Å°æ±Ù¸¶ºñ
  • reflex paralysis
    ¹Ý»ç¸¶ºñ
  • residual paralysis
    ÈÄÀ¯¸¶ºñ
  • segmental paralysis
    ºÐÀý¸¶ºñ
  • sensory paralysis
    °¨°¢¸¶ºñ
  • spasmodic spinal paralysis
    (¢¡spastic spinal paralysis) °æÁ÷ô¼ö¸¶ºñ
  • spastic paralysis
    °æÁ÷¸¶ºñ
  • spastic spinal paralysis
    °æÁ÷ô¼ö¸¶ºñ
  • stationary paralysis
    Á¤Áö¼º¸¶ºñ
  • thyrotoxic periodic paralysis
    °©»ó»ùÁßµ¶ÁÖ±âÀû¸¶ºñ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • nuclear pore
    ÇÙ
  • nuclear pore
    ÇÙ±¸¸Û
  • nuclear power
    ÇÙ·Â
  • nuclear power
    ÇÙ·Â.
  • nuclear powered pacemaker
    ÇÙÀüÁö½É¹Ú Á¶À²±â.
  • nuclear proliferation =nucleosis
    ÇÙÁõ½Ä(ú·ñòãÖ).
  • nuclear protein antigen
    Çٴܹé(Áú)Ç׿ø
  • nuclear radiation exposure
  • nuclear radius
    Çٹݰæ
  • nuclear radius
    Çٹݰæ(ú·ÚâÌÓ).
  • nuclear reaction
    ÇÙ¹ÝÀÀ
  • nuclear reaction
    ÇÙ¹ÝÀÀ.
  • nuclear rest
    ÇÙÈÞÁö(ú·ýÌò­).
  • nuclear reticulum
    ÇÙ(¼¼)¸Á(ú·á¬ØÑ).
  • nuclear saccule
    ÇÙÁÖ¸Ó´Ï
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
NMR Nuclear Magnetic Resonance; ÇÙÀڱ⠰ø¸í¼ú
PMN Poly-Morpho-Nuclear Leukocytes
PMNL Poly-Morpho-Nuclear neutrophilic Leukocyte
ACNM American College of Nuclear Medicine; American College of Nurse-Midwives
ACNP acute care nurse practitioner; American College of Nuclear Physicians
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
ANA Anti-nuclear autoantibodies
ANF Anti-nuclear factor
PCNA Antiproliferating cell nuclear antigen
AgNOR argyrophilic nuclear organiser region
Arnt Aryl hydrocarbon receptor nuclear translocator
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • muscular paralysis
    ±Ù ¸¶ºñ
  • myopathic paralysis
    ±Ù¼º ¸¶ºñ
    1. ±ÙÀ° ÀÚüÀÇ Áúȯ¿¡ ÀÇÇÑ ¸¶ºñ. 2. ±Ù·Â ÀúÇÏ µµ´Â Á¤»óÀûÀÎ ¿îµ¿À» ÇÒ ¼ö ¾ø´Â ¿øÀÎÀÌ ±Ù¿ø¼ºÀÇ ±Ù Áúȯ¿¡ ÀÖ´Â °æ¿ì¸¦ °¡¸®Å²´Ù. ±Ù ÀÌ¿µ¾çÁõ¿¡ À־´Â ±Ù¸·ÀÇ º´º¯À̰í Áö°¢ Àå¾Ö, ÀÇ½Ä Àå¾Ö´Â ³ªÅ¸³ªÁö ¾Ê´Âµ¥ Ư¡ÀûÀÎ Áõ»óÀ¸·Î¼­ ü°£±ÙÀÇ ±Ù·Â ÀúÇÏ¿¡ µû¸¥ ¿äÃß Àü¸¸ÀÇ Áõ°¡, µ¿¿ä¼º ÆÄÇà µîÀ» º¼ ¼ö ÀÖ°í ¾È¸é±ÙÀÌ Ä§¹üµÇ¸é ´«À» ¿ÏÀüÈ÷ ´ÝÀ» ¼ö°¡ ¾ø¾î Ç¥Á¤ÀÌ ºÎÁ·ÇÏ°Ô µÇ°í ¿ô¾úÀ» ¶§¿¡ ±¸°¢À» ²ø¾î¿Ã¸®Áö ¸øÇØ ¿·À¸·Î ¿ô´Â ¸ð½ÀÀ» ³ªÅ¸³½´Ù. ¶Ç ´«°ú ÀεÎÇü ±Ù ÀÌ¿µ¾çÁõ¿¡¼­´Â ¿Ü¾È±Ù¿¡ ¿µÇâÀ» ÁÖ°í ¾È°Ë Çϼö, ¾È±¸ ¿îµ¿ Àå¾Ö¸¦ ³ªÅ¸³»¼­ ¿¬Çϱٵµ Àå¾Ö¸¦ ÀÏÀ¸Å²´Ù.
  • narcosis paralysis
    ¸¶Ãë ¸¶ºñ
    ¸¶Ãë ÁßÀÇ ¸¶ºñ·Î¼­ ¾Ð¹Ú, ÇÑ·© ¹× Å¥¶ó·¹ µî¿¡ ÀÇÇØ ÀϾ´Ù.
  • oculomotor nerve paralysis
    µ¿¾È ½Å°æ ¸¶ºñ
    µ¿¾È ½Å°æÀÇ ¸¶ºñ. ½Å°æÀÌ ¿ÏÀüÈ÷ ¸¶ºñµÇ¸é ¾È°Ë
  • palatal paralysis
    ±¸°³ ¸¶ºñ
  • papalate paralysis
    ±¸°³ ¸¶ºñ
  • paralysis
    ¸¶ºñ
    1. ¸¶ºñ
  • paralysis agitans
    ÁøÀü ¸¶ºñ
    ¿¬¼ÒÇüµµ ÀÖÁö¸¸ º¸ÅëÀº ³ë³â±â¿¡ »ý±â´Â ¿øÀÎ ºÒ¸íÀÇ Parkinson ±ºÀÇ ÇÑ ÇüÀ¸·Î ¼­¼­È÷ ÁøÇàÇÏ¸ç °¡¸é»ó ¾È¸ð, Á¤Áö½ÃÀÇ Æ¯Â¡Àû ÁøÀü, ¿Ï¼­ÇÑ ¼öÀÇ ¿îµ¿, ƯÀÌÇÑ ÀÚ¼¼ ¹× ±ÙÀ°ÀÇ ¼è¾à µîÀÌ Æ¯Â¡ÀÌ´Ù. ¹ßÇÑ °úÀ×, ÇѱⰡ ÀÖ´Â ¼öµµ ÀÖ´Ù.
  • paralysis glossolabiopharyngea cerebralis
    ³ú¼º ¼³¼ø ÀεÎ
  • paralysis of conjugate movement
    °øµ¿ ¿îµ¿ ¸¶ºñ
  • paralysis of divergence
    ´« ¹ú¸² ¸¶ºñ
  • paralysis of glottis
    ¼º´ë ¸¶ºñ
  • paralysis of right external rectus
    ¿ì¿ÜÁ÷±Ù ¸¶ºñ
  • paralysis of the eye muscle
    ¾È¸é ¸¶ºñ
    ¾È±ÙÀÌ ¸¶ºñµÇ¾î ´«ÀÇ ¿îµ¿ÀÌ Á¦ÇѵǴ Áõ¼¼. ´«ÀÇ ¿îµ¿Àº 6°³ÀÇ ¿Ü¾È±Ù¿¡ ÀÇÇÏ¿© ÀÌ·ç¾îÁö°í ÀÖÀ¸¸ç, ÀÌµé ±ÙÀº ÀÏÁ¤ÇÑ ±äÀå »óŸ¦ Ç×»ó À¯ÁöÇϰí Àֱ⠶§¹®¿¡ ´«ÀÌ Á¤»ó À§Ä¡¸¦ À¯ÁöÇϰí ÀÖ´Â ¼ÀÀÌ´Ù. ±×·¯³ª ÀÌµé ±ÙÀÌ ¸¶ºñµÇ¸é ¾È±¸ ¿îµ¿ÀÇ Á¦ÇÑ, º¹½Ã, ¸¶ºñ¼º »ç½Ã, Çö±âÁõ, À§Ä¡ÀÇ ¿ÀÀÎ, µÎºÎÀÇ °æ»ç µîÀÌ Áõ¼¼·Î ³ªÅ¸³­´Ù. À̵é Áõ¼¼ÀÇ ´ëºÎºÐÀº º¹½Ã¸¦ °¡±ÞÀû Àû°Ô Çϱâ À§Çؼ­ ÀϾ´Â °ÍÀÌ´Ù. ¾È±Ù ¸¶ºñÀÇ Á¾·ù´Â ³úÀúÀÇ º´º¯¿¡ ÀÇÇÏ¿© ÀϾ´Â °æ¿ì°¡ ¸¹±â ¶§¹®¿¡ ¿ÜÀ̱٠¸¶ºñ, µ¿¾È ½Å°æ ¸¶ºñ, »ó»ç±Ù ¸¶ºñÀÇ ÇüÀ» ÃëÇÏ´Â ÀÏÀÌ ¸¹´Ù. ¿øÀÎÀº ºÒ¸íÇÑ °ÍÀÌ ÀûÁö ¾ÊÁö¸¸, ³úÀúÀÇ ¸Åµ¶, ¿°Áõ, Á¾¾ç, ÃâÇ÷, °ñÀý, ³úÀÇ ¿°Áõ, Á¾¾ç, ÃâÇ÷, ¿¬È­, ¾È¿ÍÀÇ ¿°Áõ, Á¾¾ç, ÃâÇ÷ ¹× ¿Ü»ó µîÀ» »ý°¢ÇÒ ¼ö ÀÖ´Ù. Ä¡·á¹ýÀº ¿øÀÎ ¿ä¹ýÀÌ °¡Àå ÁÁ°í, ¿øÀÎ ºÒ¸íÀÏ ¶§´Â ºñŸ¹ÎÁ¦, »ì¸®½Ç»êÁ¦, ¿ä¿ÀµåÁ¦ µîÀÌ ¾²ÀÌÁö¸¸, Àß ³´Áö ¾Ê´Â °æ¿ì°¡ ¸¹´Ù.
  • paralysis, peripheral vocal cord
    ¸»Ãʼº ¼º´ë ¸¶ºñ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
nuclear scan: adrenals A nuclear scan that images the adrenal glands after a radioactive tracer is injected into the bloodstream. This test is useful in detecting a pheochromocytoma, particularly if it not within the adrenal gland.
(27 Sep 1997)
nuclear sclerosis Increased refractivity of the central portion of the lens of the eye.
See: nuclear cataract.
(05 Mar 2000)
nuclear spindle See: spindle and mitosis.
(18 Nov 1997)
nuclear stain <technique> A stain for cell nuclei, usually based on the binding of a basic dye to DNA or nucleohistone.
(05 Mar 2000)
nuclear transplantation <procedure> Experimental approach in study of nucleo cytoplasmic interactions, in which a nucleus is transferred from one cell to the cytoplasm (which may be anucleate) of a second.
(18 Nov 1997)
nuclear transport <cell biology> Passage of molecules in and out of the nucleus, presumably via nuclear pores. Passage of proteins into the nucleus may depend on possession of a nuclear location sequence containing five consecutive positively charged residues PKKKRKV).
(18 Nov 1997)
nuclear warfare Warfare involving the use of nuclear weapons.
(12 Dec 1998)
nucleolar-nuclear ratio Ratio of volume of nucleolus to volume of nucleus, usually increased in malignant neoplasms.
(05 Mar 2000)
direct nuclear division <cell biology> An unusual form of nuclear division, in which the nucleus simply constricts, rather like a cell without chromosome condensation or spindle formation. Partitioning of daughter chromosomes is haphazard. Observed in some Protozoa.
(18 Nov 1997)
indirect nuclear division <cell biology> A method of indirect division of a cell, consisting of a complex of various processes, by means of which the two daughter nuclei normally receive identical complements of the number of chromosomes characteristic of the somatic cells of the species. Mitosis, the process by which the body grows and replaces cells, is divided into four phases.
1. Prophase: formation of paired chromosomes, disappearance of nuclear membrane, appearance of the achromatic spindle, formation of polar bodies.
2. Metaphase: arrangement of chromosomes in the equatorial plane of the central spindle to form the monaster. Chromosomes separate into exactly similar halves.
3. Anaphase: the two groups of daughter chromosomes separate and move along the fibres of the central spindle, each toward one of the asters, forming the diaster.
4. Telophase: the daughter chromosomes resolve themselves into a reticulum and the daughter nuclei are formed, the cytoplasm divides, forming two complete daughter cells.
NOTE: the term mitosis is used interchangeably with cell division, but strictly speaking it refers to nuclear division, whereas cytokinesis refers to division of the cytoplasm. In some cells, as in many fungi and the fertilized eggs of many insects, nuclear division occurs within the cell unaccompanied by division of the cytoplasm and formation of daughter cells.
(13 Nov 1997)
internal nuclear layer of retina The intermediate layer of neurons in the retina composed largely of bipolar cells.
Synonym: internal nuclear layer of retina, stratum ganglionare retinae, stratum nucleare internum retinae.
(05 Mar 2000)
epstein-barr virus nuclear antigens Nuclear antigens encoded by epstein-barr virus genes. at least six nuclear antigens have been identified but their mechanism of action and role in B-cell transformation is still unknown.
(12 Dec 1998)
external nuclear layer of retina The outermost layer of the cerebral layer of retina, composed of the primary receptor cells of the retina; the stratum consists of two sublayers: 1) an external layer made up of the rods and cones, the photosensitive processes of the receptor cells, and 2) the external nuclear layer containing the cell bodies of these cells; the external limiting membrane forms a perforated supporting plate between the two sublayers; the name refers to the fact that the retinal receptor cells are a specialised form of (epithelial) ependyma cell and thus, in a sense, are comparable to the neuroepithelial cells (e.g., hair cells) of other sense organs.
Synonym: external nuclear layer of retina, stratum neuroepitheliale retinae, stratum nucleare externum retinae.
(05 Mar 2000)
U1 small nuclear RNA-(guanosine-N2)-methyltransferase <enzyme> A trans-active non-small nuclear ribonucleoprotein; facilitates the formation of the m3g cap
Registry number: EC 2.1.1.-
Synonym: u1 snrna(g-n2)mtase
(26 Jun 1999)
U6 small nuclear RNA methyltransferase <enzyme> Methylates gamma-phosphate residues in rnas; distinct from u6 snrna n6-adenosine methyltranferase; mw 130 kD; from hela cells
Registry number: EC 2.1.1.-
Synonym: u6 snrna capping enzyme
(26 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á